Search In this Thesis
   Search In this Thesis  
العنوان
Effect of Sofosbuvir and Daclatasvir on Platelet Factor 4 in chronic Hepatitis C Patients /
المؤلف
Hamoud, Fatma Abdelnasser Abdelkader.
هيئة الاعداد
باحث / فاطمة عبدالناصر عبدالقادر حمود
مشرف / محمود فاروق سليم
مناقش / محمد عطيه سعد
مناقش / نهي السيد عشيبه
الموضوع
Internal Medicine.
تاريخ النشر
2021.
عدد الصفحات
p 71. :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
الطب الباطني
تاريخ الإجازة
20/6/2021
مكان الإجازة
جامعة طنطا - كلية الطب - Internal Medicine
الفهرس
Only 14 pages are availabe for public view

from 114

from 114

Abstract

Egypt has the highest hepatitis C virus (HCV) prevalence worldwide, with an estimated overall prevalence of 21.9% among adults.)1 HCV-induced inflammatory and immunological phenomena in the liver tissues are assumed to be directly responsible for in-vivo platelet activation.)2( Accordingly, activated platelets are considered to play a significant role in the pathogenesis of liver damage by stimulating fibrogenesis and mitogenesis of the liver cells.)3 Platelet factor 4 (PF4), also known as chemokine CXCL4, is released from the alpha-granules of activated platelets as a complex with a chondroitin sulfate proteoglyan carrier.)4 It disappears rapidly from plasma as it transfers to higher affinity heparin sulfate on endothelial cells, inhibiting local antithrombin (AT) activity and thus promoting coagulation.)5(